MODTX
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Modus Therapeutics operates in biotechnology. The product portfolio includes the drug candidate sevuparin. The company's focus is to develop sevuparin for patients with sepsis, septic shock and other conditions with systemic inflammation. In addition to its core business, it also offers service and related ancillary services. The business and related research are conducted with the largest presence in Sweden.
Read moreEPS (adj.)
Dividend %
Interim report Q2'26
Interim report Q3'26
Annual report '26
Don't miss out - create an account and get all the possible benefits